Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Mangalam Drugs & Organics Ltd - 532637 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 In compliance of provisions of Regulations 47 of the SEBI (Listing Obligations and Disclosure Requirements)Regulations, 2015, we are pleased to enclose copies each of Free Press Journal (English Daily)and Navshakti (Marathi Daily)both dated 12th February, 2019 in which un-audited financial results of the company for the quarter ended 31st December, 2018, have been published. The aforesaid results have been approved by the Board of Directors in its meeting held on 11th February, 2019.
12-02-2019
Bigul

Mangalam Drugs & Organics Ltd - 532637 - Results- Financial Results For December 31, 2018

 In terms of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we are enclosing herewith Un-audited Financial Results for the quarter ended 31st December, 2018 along with Limited Review Report of the said period in the prescribed form which have been taken on record and approved by the Board of Directors of the company in its meeting held today i.e. 11th February, 2019 at Mumbai. Kindly note that meeting of Board of Directors commenced at 12.00 P.M. and concluded at 3.20 P.M.
11-02-2019
Bigul

Mangalam Drugs & Organics Ltd - 532637 - Outcome of Board Meeting

 In terms of Regulation 30 read with part A of Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, this is to inform you that, the meeting of Board of Directors was held today i.e. Monday, 11th February, 2019 at 12.00 P.M at the time scheduled for the meeting at the registered office of the company, where in the following business was inter-alia transacted: 1. Approved the Un-Audited Financial Results for the quarter and nine months ended 31st December, 2018 along with the Limited Review Report on the results pursuant to Regulation 33 of the SEBI (LODR) Regulations, 2015; 2. Other Business transacted with permission of chair. The Board Meeting concluded at 3.20 P.M. You are requested to take the same on your records.
11-02-2019
Bigul

Mangalam Drugs & Organics Ltd - 532637 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for SICOM Ltd
08-02-2019
Bigul

Mangalam Drugs & Organics Ltd - 532637 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Raj Exports Pvt Ltd
06-02-2019
Bigul

Mangalam Drugs & Organics Ltd - 532637 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Raj Exports Pvt Ltd
01-02-2019
Bigul

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Board Meeting Intimation for Board Meeting To Consider The Unaudited Financial Results For The Quarter & Nine Months Ended 31St December, 2018.

 MANGALAM DRUGS & ORGANICS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2019 ,inter alia, to consider and approve Un-audited Financial Results along with Limited review report of the company for the quarter ended 31st December, 2018 and any other matters with the permission of the chair.
29-01-2019
Bigul

Mangalam Drugs & Organics Ltd - 532637 - Statement Of Investor Complaints For The Quarter Ended December 2018

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Nikita BavishiDesignation :- Company Secretary and Compliance Officer
07-01-2019
Bigul

Mangalam Drugs & Organics Ltd - 532637 - Shareholding for the Period Ended December 31, 2018

 Mangalam Drugs & Organics Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2018. For more details, kindly Click here
07-01-2019
Bigul

Announcement Under Regulation 30 (LODR) - Updates

 Pursuant to Regulation 30 of the Listing Regulations and with reference to the captioned subject, this is to inform you that our Unit-1 facility was recently inspected by WHO prequalification team and the Company is pleased to inform you that we have received the WHO Pre-qualification approval for our Unit-1. We request you to take on record the aforesaid information.
07-12-2018
Next Page
Close

Let's Open Free Demat Account